Sebastiano A. G. Lava & Nicole Sekarski Heart Failure and Transplantation, Department of Paediatric Cardiology, Great Ormond Street Hospital, London, UK Sebastiano A. G. Lava, Craig Laurence & Michael Burch Clinical Pharmacology and Therapeutics Group, University College London, London, UK Sebastiano...
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective. Heart. 2014;100(13):1031-1036. doi:10.1136/heartjnl-2013-304598 PubMedGoogle ScholarCrossref 44. McMurray JJV, Trueman D, Hancock E, et al. ...
Oral semaglutide versus empagliflozin, sitagliptin and liraglutide in the UK: long-term cost-effectiveness analyses based on the PIONEER clinical trial programme. Diabetes Ther. 2020;11(1):259–277. doi:10.1007/s13300-019-00736-6 32. Malkin SJP, Hunt B, Huisman EL, Grand TS, Chubb B. The...
C. et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358, 2545–2559 (2008). 6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients ...
Oral semaglutide versus empagliflozin, sitagliptin and liraglutide in the UK: long-term cost-effectiveness analyses based on the PIONEER clinical trial programme. Diabetes Ther. 2020;11(1):259–277. doi:10.1007/s13300-019-00736-6 32. Malkin SJP, Hunt B, Huisman EL, Grand TS, Chubb B. The...
C. et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358, 2545–2559 (2008). Article CAS Google Scholar UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of ...
The present experiment aimed to identify the potential protective role of empagliflozin (EMPA) on haloperidol (HAL)-induced ovarian damage in female rats because of its anti-inflammatory, antioxidant, and antiapoptotic effects. EMPA was administered in the presence and absence of HAL. Thirty-two adul...
(SGLT-2), that inhibit reabsorption of urinary glucose and they are able to reduce hyperglycemia in patients with type 2 diabetes. A renoprotective function of gliflozins has been proven in diabetic nephropathy, but harmful side effects on the kidney have also been described. In the current ...